All In Biotech

Free tool

FAERS Monitor: Lumason

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 203684 or its brand name (Lumason, Sulfur Hexafluoride Lipid-Type A Microspheres). Reports on generic versions are filed under their own applications.

Reports

1,980

Serious

1,360

69% of reports

Hospitalization

482

Death reported

101

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea335
  • nausea277
  • anaphylactic reaction252
  • hyperhidrosis231
  • flushing196
  • hypotension168
  • dizziness162
  • feeling hot157
  • hypersensitivity136
  • erythema135
  • blood pressure decreased125
  • unresponsive to stimuli123
  • pruritus120
  • paraesthesia119
  • cardiac arrest116

Reports by year received

View as table
YearReports
201217
20139
20141
20151
201622
201734
201860
201969
202072
2021129
2022215
2023448
2024280
2025277
2026346

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,179 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
unresponsive to stimuliSignal12350.942.85,941
anaphylactic reactionSignal25248.743.311,694
feeling hotSignal15727.323.53,948
flushingSignal19620.518.03,630
blood pressure decreasedSignal12520.016.92,242
hyperhidrosisSignal23119.116.93,957
cardiac arrestSignal11614.912.51,499
hypotensionSignal1688.97.71,181
paraesthesiaSignal1198.06.8732
hypersensitivitySignal1367.86.6804
erythemaSignal1357.05.9692
dyspnoeaSignal3356.35.71,525
nauseaSignal2773.73.3569
dizzinessSignal1623.53.0286
pruritusSignal1203.32.8195

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.